Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01658657 · ClinicalTrials.gov registry record · NA
A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01658657 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 17 participants.
The verdict
NCT01658657, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effect of plasma renin activity-guided therapy for determining hypertension treatment. Plasma renin is an enzyme in your blood that can be measured to determine your hypertension subtype. Once the subtype is known, doctors can prescribe specific medications to target your specific hypertension subtype. This study will investigate whether targeting the specific hypertension subtype helps to achieve blood pressure control sooner and with fewer medications compared to a standard fixed dose combination therapy.
Interventions
- DRUG Amlodipine
- DRUG Lisinopril
- DRUG metoprolol
- DRUG Hydrochlorothiazide
- DRUG lisinopril/hydrochlorothiazide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-10 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01658657
The ClinicalTrials.gov registry entry for NCT01658657 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Amlodipine is the first listed.
NCT01658657 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01658657 about?
NCT01658657 is a clinical study titled "A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension". The purpose of this study is to investigate the effect of plasma renin activity-guided therapy for determining hypertension treatment. Plasma renin is an enzyme in your blood that can be measured to determine your hypertension subtype. Once the subtype is known, doctors can prescribe specific medica...
What is the current status of trial NCT01658657?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2012-10. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01658657?
The interventions under investigation include: Amlodipine (DRUG), Lisinopril (DRUG), metoprolol (DRUG), Hydrochlorothiazide (DRUG), lisinopril/hydrochlorothiazide (DRUG).
Who is sponsoring clinical trial NCT01658657?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.